Difference between revisions of "Mirtazapine-amitriptyline"

From Psychiatrienet
Jump to: navigation, search
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
| to = amitriptyline  
| to = amitriptyline  
| stop =  
| stop =  
* '''Day 0:''' gradually reduce dosage of mirtazapine to a maximum of 30 mg/ day.
* '''Day 1:''' reduce a dosage of 30 mg/day to 15 mg/day.
* '''Day 8:''' stop administration of mirtazapine.
| start =
| start =
No wash-out period is needed.
* '''Day 1:''' simultaneously start administration of amitriptyline in a dosage of 50 mg/day.
* '''Day 8:''' If necessary, increase dosage of amitriptyline.
| info =
* Start low, go slow.}}
* No wash-out period is needed.

Latest revision as of 11:49, 21 October 2015

Type Antidepressant
Group other
Medscape Mirtazapine
PubChem 4205
PubMed Mirtazapine
Kompas (Dutch) Mirtazapine
Wikipedia Mirtazapine
Type Antidepressant
Group TCA
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline

Switch medication from mirtazapine to amitriptyline.

Nietinrijdenbord.png Stop mirtazapine
  • Before day 1: Gradually reduce dosage of mirtazapine to a maximum of 30 mg/day, when this dosage is > 30 mg/day.
  • Day 1: Reduce dosage of mirtazapine to 15 mg/day.
  • Day 8: Stop administration of mirtazapine.
Eenrichtingbord.png Start amitriptyline
  • Day 2: Start with normal dosage and increase with about 25% (up to 50%) every 3 days to target dose.
Infobord.png More information
  • No wash-out period is needed.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.